The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia

Stephen E. Spurgeon(Howard Hughes Medical Institute), Marc Loriaux(Oregon Health & Science University)
Journal of Pharmacology and Experimental Therapeutics
December 8, 2012
Cited by 53


Related Papers

No related papers found

Powered by citation graph analysis